PeptideHub
Home
PeptidesCalculatorProtocolsSchedule
HomePeptidesCalculatorProtocolsSchedule
Back to Encyclopedia
Healing & RecoveryPreclinicalIntermediate

Pentadecapeptide BPC

Pentadecapeptide Body Protection Compound

Also known as: BPC Variant, Stable BPC, BPC-157 Analog

Overview

A stabilized variant of the BPC pentadecapeptide family, designed to improve bioavailability and extend activity. Shares the core healing mechanisms of BPC-157 with modifications aimed at enhanced oral stability.

Half-Life
4-6 hours (estimated)
Typical Dose
250–500 mcg
Frequency
1-2x daily
Cycle Length
4-12 weeks

Administration

SubcutaneousOral

Benefits

  • Enhanced oral bioavailability compared to BPC-157
  • GI tract healing and protection
  • Tendon and ligament repair support
  • Systemic anti-inflammatory effects
  • Cytoprotective properties

Side Effects

  • Nausea (rare)
  • Injection site irritation
  • Mild headache (uncommon)

Mechanism of Action

  • Modulates nitric oxide system for tissue repair
  • Promotes angiogenesis through VEGF pathways
  • Enhances growth factor receptor expression in damaged tissue
  • Protects endothelial cells from oxidative stress

Contraindications

  • Active cancer
  • Pregnancy or breastfeeding
  • Concurrent use with anticoagulants (consult physician)

Storage & Reconstitution

Store at 2–8°C (36–46°F) for up to 3 months. For long-term storage, keep at -20°C (-4°F). Once reconstituted, refrigerate and use within 2-4 weeks. Oral formulation: store in a cool, dry place.

Common peptide amounts:3 mg5 mg10 mg

Research Summary

Preclinical data supports similar healing profiles to BPC-157 with potentially improved pharmacokinetics for oral dosing. Limited published literature compared to BPC-157; most data derives from comparative analog studies.

Commonly Stacked With

Healing & RecoveryTB-500
Healing & RecoveryGHK-Cu

This information is for educational purposes only. Always consult a qualified healthcare professional before using any peptide.